Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.91
0.10 (1.47%)
At close: Aug 19, 2025, 2:40 PM
Day One Biopharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -95M | -69.08M | -95.5M | -84.29M | -167.48M | -208.94M | -188.92M | -174.51M | -166.16M | -156.83M | -142.18M | -124.01M | -105.46M | -84.4M | -72.75M | -86.42M | -71.02M | -57.95M |
Depreciation & Amortization | 3.21M | 2.73M | 2.03M | 1.37M | 726K | 410K | 383K | 460K | 526K | 567K | 531K | 402K | 287K | 203K | 199K | 197K | 193K | 190K |
Stock-Based Compensation | 46.35M | 48.48M | 48.26M | 48.04M | 46.09M | 42.54M | 39.34M | 35.36M | 34.33M | 30.49M | 27.24M | 25.51M | 22.08M | 18.98M | 13.32M | 8.57M | 3.48M | 1M |
Other Working Capital | -42.09M | 16.51M | 42.91M | 15.3M | 62.16M | 3.02M | 7.1M | 4.98M | 8.12M | 10.17M | 8.05M | 8.13M | 6.27M | 4.84M | 1.15M | -1.42M | -3.17M | -2.78M |
Other Non-Cash Items | 42.62M | -50.09M | -36.53M | -76.86M | -84.34M | 2.9M | -7.08M | 35.08M | -12.11M | -2.89M | -2.29M | -1.31M | -276K | -7K | 8M | 38.03M | 38.03M | 38.03M |
Deferred Income Tax | n/a | n/a | n/a | 41.58M | -4.22M | n/a | n/a | -41.58M | 4.22M | n/a | n/a | n/a | n/a | n/a | n/a | -578K | -308K | -218K |
Change in Working Capital | -60.24M | -7.24M | 26.48M | 3.55M | 54.78M | 3.16M | 9.42M | 4.4M | 12.25M | 14.11M | 6.56M | 11.42M | 6.36M | 4.86M | 2.69M | -1.11M | -3.05M | -2.21M |
Operating Cash Flow | -63.06M | -87.38M | -78.11M | -89.48M | -177.29M | -170.6M | -146.85M | -140.79M | -126.94M | -114.3M | -109.87M | -87.73M | -76.74M | -60.36M | -48.54M | -41.31M | -32.66M | -21.15M |
Capital Expenditures | -57.46M | -78.09M | -74.27M | -72.86M | -20.18M | -3.2M | -3.22M | -3.22M | -179K | -37K | -26K | 7.97M | 7.98M | 7.99M | n/a | -8M | -8M | -8M |
Cash Acquisitions | n/a | n/a | n/a | -2.99M | 9.26K | -11.17K | n/a | 2.99M | -20.01M | -19.99M | -20M | -20M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -918.15M | -801.25M | -658.62M | -482.53M | -347.86M | -330.99M | -443.84M | -466.07M | -652.96M | -554.22M | -394.21M | -272.84M | -5.99M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 635.45M | 418.44M | 393.89M | 516.42M | 485.67M | 563.04M | 575.44M | 565.07M | 413.16M | 288M | 139.16M | 20M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -75.57M | 32.4M | 125.19M | 145.28M | 197.28M | 89.3M | n/a | -2.99M | 20.01M | 14M | 14.01M | 6.01M | -13.99M | -8M | -8M | n/a | n/a | n/a |
Investing Cash Flow | -343.63M | -352.89M | -230.99M | 69.03M | 225.64M | 228.86M | 128.38M | 95.79M | -239.98M | -266.25M | -255.07M | -244.86M | 1.99M | 7.99M | n/a | -8M | -8M | -8M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 748K | n/a | n/a | 1.25M | 1.25M | 1.25M | 1.25M | n/a | n/a | n/a | n/a | 318K | 318K | 318K | 318K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 23.77M | 25.07M | 25.11M | 23.86M | 2.06M | 162.86M | 164M | 165.32M | 167.26M | 167.09M | 165.9M | 164.3M | 162.25M | 168.85M | 167.98M | 167.66M | 167.66M | -872K |
Financial Cash Flow | 202.69M | 203.24M | 203.29M | 202.04M | 2.06M | 162.86M | 164M | 165.32M | 167.26M | 167.09M | 165.9M | 164.3M | 161.63M | 168.24M | 297.12M | 326.78M | 327.39M | 158.86M |
Net Cash Flow | -203.99M | -237.03M | -105.82M | 181.59M | 50.41M | 221.12M | 145.52M | 120.31M | -199.67M | -213.46M | -199.05M | -176.3M | 78.88M | 107.86M | 240.58M | 277.47M | 286.73M | 129.71M |
Free Cash Flow | -120.52M | -165.47M | -152.38M | -162.34M | -197.47M | -173.79M | -150.08M | -144.01M | -127.12M | -114.33M | -109.9M | -79.76M | -68.76M | -52.37M | -48.54M | -49.31M | -40.66M | -29.15M |